Literature DB >> 19485797

Simian foamy virus infection in humans: prevalence and management.

Arifa S Khan1.   

Abstract

Simian foamy viruses (SFVs) are highly prevalent in all nonhuman primate species and can infect humans following occupational and non-occupational exposure to infected animals and their tissues, blood or body fluids. Virus transmission results in a stable, persistent infection that seems to be latent. SFV infections are thus far nonpathogenic, with no evidence of adverse clinical outcome in their natural nonhuman primate hosts or by experimental injection in animals and upon cross-species transmission in humans. Since the emergence of pathogenic viruses from nonpathogenic viruses upon cross-species infection is well-documented for several retroviruses, it is prudent to take necessary precautions to deter SFV infections in humans. These steps will help prevent the emergence of a novel pathogen and reduce the risk of transmission of another potential pathogenic human retrovirus.

Entities:  

Mesh:

Year:  2009        PMID: 19485797     DOI: 10.1586/eri.09.39

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  39 in total

1.  Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa.

Authors:  Augustin Mouinga-Ondémé; Mélanie Caron; Dieudonné Nkoghé; Paul Telfer; Preston Marx; Ali Saïb; Eric Leroy; Jean-Paul Gonzalez; Antoine Gessain; Mirdad Kazanji
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from Macaca cyclopis.

Authors:  Teresa A Galvin; Imran A Ahmed; Muhammad Shahabuddin; Theodore Bryan; Arifa S Khan
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 3.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

4.  Generation of a specific-pathogen-free baboon colony.

Authors:  Roman F Wolf; Richard Eberle; Gary L White
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

Review 5.  Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.

Authors:  Yingying Zhang; Yongjuan Liu; Guoguo Zhu; Yanyan Qiu; Biwen Peng; Jun Yin; Wanhong Liu; Xiaohua He
Journal:  J Neurovirol       Date:  2010-10-25       Impact factor: 2.643

6.  Two distinct variants of simian foamy virus in naturally infected mandrills (Mandrillus sphinx) and cross-species transmission to humans.

Authors:  Augustin Mouinga-Ondémé; Edouard Betsem; Mélanie Caron; Maria Makuwa; Bettina Sallé; Noemie Renault; Ali Saib; Paul Telfer; Preston Marx; Antoine Gessain; Mirdad Kazanji
Journal:  Retrovirology       Date:  2010-12-14       Impact factor: 4.602

Review 7.  Simian herpesviruses and their risk to humans.

Authors:  Ryan D Estep; Ilhem Messaoudi; Scott W Wong
Journal:  Vaccine       Date:  2010-05-26       Impact factor: 3.641

8.  In vivo cellular tropism of gorilla simian foamy virus in blood of infected humans.

Authors:  Rejane Rua; Edouard Betsem; Thomas Montange; Florence Buseyne; Antoine Gessain
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

9.  Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Mario Perkovic; Yannick Bulliard; Klaus Cichutek; Didier Trono; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

10.  Lentivirus restriction by diverse primate APOBEC3A proteins.

Authors:  Kimberly Schmitt; Kejun Guo; Miki Katuwal; Darayu Wilson; Courtney Prochnow; Ronda Bransteitter; Xiaojiang S Chen; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2013-05-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.